Measles, Mumps, Rubella And Varicella Vaccine
Recommended · restricted VaccinesRestrictedNot applicable line
Active immunization against measles, mumps, rubella and varicella in children aged 12 months.
1
Submissions
2007–07
On the record
$15k–45k
ICER range
1 sourced ICER · 2007
ICER stated
Cost basis
Access path
- Nov 2007Recommended · restricted
vs MMR vaccine at 12 months and MMR co-administered with…
- PBS listing · Restricted
RecommendedDeferredNot recommended
Cost-effectiveness
ICER range reported by submission for both ATAGI preferred and alternative schedules; PBAC noted concerns with the modelled economic evaluations and rejected the cost-effectiveness basis for the two-dose MMRV schedule.
The ICERs for the 2 dose MMRV vaccination schedule were substantially influenced by the numbers and severity of zoster infections included in the model and the disutility associated with them. PBAC · 2007
Decision context
PopulationHealthy children aged 12 to 18 months for primary immunization against measles, mumps, rubella and varicella.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Nov 2007 | Recommended · restricted | MMR vaccine at 12 months and MMR co-administered with varicella vaccine at 18 months of age | $15k–45k | RCT |